Stocks and securities in focus
| Security | Change (%) | 1w | 1m | 1y ▲ | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Apellis Pharmaceuticals | -1.890% | - | - | - | - | - | - |
| Revance Therapeutics Inc. | -22.280% | - | - | - | - | - | - |
| Amneal Pharmaceuticals Inc | 0.830% | - | - | - | - | - | - |
| Salarius Pharmaceuticals Inc. | 2.480% | -8.811% | 2.985% | -70.216% | -25.405% | -98.392% | -99.993% |
| Gritstone Oncology Inc | -17.770% | -18.396% | -16.952% | -69.813% | -60.845% | -90.515% | - |
| MacroGenics Inc. | -77.710% | -78.352% | -81.918% | -53.424% | -65.844% | -88.752% | - |
| X4 Pharmaceuticals, Inc. | -2.410% | -8.714% | -14.826% | -32.911% | 25.577% | - | - |
| Fate Therapeutics Inc. | 9.850% | 0.317% | -38.485% | -21.923% | 6.665% | -93.920% | - |
| Inogen Inc. | 2.610% | 22.901% | 12.587% | -21.078% | 51.887% | -85.364% | - |
| Ocular Therapeutix Inc. | -5.620% | -8.170% | -28.513% | -10.923% | 25.357% | -57.920% | 62.396% |
| Catalyst Pharmaceutical Partners Inc | 0.380% | 5.679% | 1.684% | -7.183% | -4.794% | 272.201% | 409.470% |
| Biolife Solutions Inc | -3.510% | -0.602% | 3.774% | -2.941% | 10.738% | -36.392% | 14.329% |
| Novavax Inc. | 97.310% | 80.837% | 108.011% | 0.917% | 84.927% | -93.750% | 26.254% |
| Cytomx Therapeutics Inc | -15.850% | -55.310% | -5.969% | 10.890% | 32.020% | -72.574% | - |
| Akebia Therapeutics Inc. | -5.620% | -12.373% | -22.668% | 19.807% | -4.522% | -53.375% | - |
| Evolus Inc | -1.650% | -3.252% | 1.709% | 39.181% | 31.492% | 59.732% | - |
| Cytokinetics Inc. | -0.840% | -4.918% | -16.547% | 66.667% | -24.183% | 198.969% | - |
| Ardelyx Inc. | -3.860% | -10.646% | 8.770% | 81.814% | 24.879% | 33.667% | - |
| Chromadex Corp | -1.120% | -2.286% | -6.044% | 155.224% | 155.224% | -44.839% | - |
| Viking Therapeutics Inc | -7.140% | -4.337% | 2.549% | 230.818% | 291.078% | 1342.616% | - |